OpenVSafe by OpenVAERS
Search V-safe

HBK-26559-14780

3 vaccinations 3 coded responses 24 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
300 / GA
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Moderna
  2. 2020-12-30
    Registered in v-safe
  3. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-12
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site swelling, Injection site warmth — Feeling: Good
    Free text: Redness, slight swelling, and warmth on site of injection over a 4 inch area on day 10-12 after injection. It faded.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-25
    Dose 2 — Moderna
  11. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Diarrhea
    Adult check-in
  13. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · Fatigue or tiredness
    Adult check-in
  14. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-02-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-26
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-12-26
    Dose 3 — Moderna
  26. 2022-01-25
    Survey response — 12 months, dose 2
    MedDRA: Benign breast neoplasm, Fatigue, Influenza — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Benign breast cyst. Fatigue. Influenza type A
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-25
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-01-27
  29. 2022-06-29
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  30. 2022-12-26
    Survey response — 12 months, dose 3
    MedDRA: Ectopic pregnancy — Feeling: Fair
    Free text: Ectopic pregnancy
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna
22021-01-25Moderna
32021-12-26Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-25 Unsuccessful

Free text

Release 1 — day 14, dose 1

2021-01-12

Symptoms: Redness, slight swelling, and warmth on site of injection over a 4 inch area on day 10-12 after injection. It faded.

Release 11 — 12 months, dose 2

2022-01-25

Symptoms: Benign breast cyst. Fatigue. Influenza type A

Release 12 — 12 months, dose 3

2022-12-26

Symptoms: Ectopic pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBenign breast neoplasm · · ✓
SDEctopic pregnancy · · ✓
SDFatigue · · ✓
SDInfluenza · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release